Geneoscopy

Saint Louis, MO · Founded 2015 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing. Geneoscopy is based in Saint Louis, MO and was founded in 2015. It was valued at $440 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $218 million across 2 recorded rounds; the latest was a $50.5 million later-stage round in May 2021.

PMV mark · valuation
$440.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$218.4M
Last round
Later Stage VC
May 2021

Who backs Geneoscopy?

24 investors
InvestorType
Dorm Room FundOther
Morningside GroupVenture capital
Cultivation CapitalVenture capital
Labcorp Venture FundVenture capital
iSelect FundVenture capital
BioGenerator VenturesVenture capital
Arch GrantsVenture capital
Missouri Technology CorporationVenture capital
Granger ManagementFamily office
Tri Locum PartnersHedge fund
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Geneoscopy investors

24 investors are on record for Geneoscopy, including Dorm Room Fund, Morningside Group, Cultivation Capital and Labcorp Venture Fund. By type, the record holds 7 venture capital firms, 1 family office and 1 hedge fund. The later-stage round in May 2021 drew 85 investors.

Free account
More of Geneoscopy with a free account
  • ·The complete investor list: 24 names
  • ·Watch Geneoscopy: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Geneoscopy. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View